
According to the January 2006 issue of the journal "
Clinical Infectious Diseases," a single day of
antiviral therapeutics has been shown to arrest the proliferation of recurring genital herpes, preventing it from progressing to a full-fledged outbreak.
In the study, a group of herpes patients (showing the first sign of a genital herpes outbreak) was given two doses of the
antiviral drug Famvir over the course of an entire day while a second group was given placebo. The research concluded that when taken within six hours of the first sympton, a significant number of patients were able to supress the viral disease, avoiding the onslaught lesions while the other experimental group experienced mild outbreaks.